Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133


Five-Antigen Fluorescent Bead-Based Assay for Diagnosis of Lyme Disease.

Embers ME, Hasenkampf NR, Barnes MB, Didier ES, Philipp MT, Tardo AC.

Clin Vaccine Immunol. 2016 Apr 4;23(4):294-303. doi: 10.1128/CVI.00685-15. Print 2016 Apr.


A fluorescent bead-based multiplex assay for the simultaneous detection of antibodies to B. burgdorferi outer surface proteins in canine serum.

Wagner B, Freer H, Rollins A, Erb HN.

Vet Immunol Immunopathol. 2011 Apr 15;140(3-4):190-8. doi: 10.1016/j.vetimm.2010.12.003. Epub 2010 Dec 10.


Development of a multiplex assay for the detection of antibodies to Borrelia burgdorferi in horses and its validation using Bayesian and conventional statistical methods.

Wagner B, Freer H, Rollins A, Erb HN, Lu Z, Gröhn Y.

Vet Immunol Immunopathol. 2011 Dec 15;144(3-4):374-81. doi: 10.1016/j.vetimm.2011.08.005. Epub 2011 Aug 17.


Prospective study of serologic tests for lyme disease.

Steere AC, McHugh G, Damle N, Sikand VK.

Clin Infect Dis. 2008 Jul 15;47(2):188-95. doi: 10.1086/589242.


Evaluation of Selected Borrelia burgdorferi lp54 Plasmid-Encoded Gene Products Expressed during Mammalian Infection as Antigens To Improve Serodiagnostic Testing for Early Lyme Disease.

Weiner ZP, Crew RM, Brandt KS, Ullmann AJ, Schriefer ME, Molins CR, Gilmore RD.

Clin Vaccine Immunol. 2015 Nov;22(11):1176-86. doi: 10.1128/CVI.00399-15. Epub 2015 Sep 16.


Improved Serodiagnostic Performance for Lyme Disease by Use of Two Recombinant Proteins in Enzyme-Linked Immunosorbent Assay Compared to Standardized Two-Tier Testing.

Bradshaw GL, Thueson RK, Uriona TJ.

J Clin Microbiol. 2017 Oct;55(10):3046-3056. doi: 10.1128/JCM.01004-17. Epub 2017 Aug 2.


Concordance of four commercial enzyme immunoassay and three immunoblot formats for the detection of Lyme borreliosis antibodies in human serum: the two-tier approach remains.

Dickeson DJ, Chen SC, Sintchenko VG.

Pathology. 2016 Apr;48(3):251-6. doi: 10.1016/j.pathol.2016.02.004. Epub 2016 Mar 5.


Development of a Multiantigen Panel for Improved Detection of Borrelia burgdorferi Infection in Early Lyme Disease.

Lahey LJ, Panas MW, Mao R, Delanoy M, Flanagan JJ, Binder SR, Rebman AW, Montoya JG, Soloski MJ, Steere AC, Dattwyler RJ, Arnaboldi PM, Aucott JN, Robinson WH.

J Clin Microbiol. 2015 Dec;53(12):3834-41. doi: 10.1128/JCM.02111-15. Epub 2015 Oct 7.


Decorin binding proteins A and B in the serodiagnosis of Lyme disease in North America.

Arnaboldi PM, Sambir M, Dattwyler RJ.

Clin Vaccine Immunol. 2014 Oct;21(10):1426-36. doi: 10.1128/CVI.00383-14. Epub 2014 Aug 13.


Outer surface protein C peptide derived from Borrelia burgdorferi sensu stricto as a target for serodiagnosis of early lyme disease.

Arnaboldi PM, Seedarnee R, Sambir M, Callister SM, Imparato JA, Dattwyler RJ.

Clin Vaccine Immunol. 2013 Apr;20(4):474-81. doi: 10.1128/CVI.00608-12. Epub 2013 Jan 30.


Significantly improved accuracy of diagnosis of early Lyme disease by peptide enzyme-linked immunosorbent assay based on the borreliacidal antibody epitope of Borrelia burgdorferi OspC.

Jobe DA, Lovrich SD, Asp KE, Mathiason MA, Albrecht SE, Schell RF, Callister SM.

Clin Vaccine Immunol. 2008 Jun;15(6):981-5. doi: 10.1128/CVI.00079-08. Epub 2008 Apr 16.


Identification of OppA2 linear epitopes as serodiagnostic markers for Lyme disease.

Signorino G, Arnaboldi PM, Petzke MM, Dattwyler RJ.

Clin Vaccine Immunol. 2014 May;21(5):704-11. doi: 10.1128/CVI.00792-13. Epub 2014 Mar 12.


Two-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassay.

Branda JA, Linskey K, Kim YA, Steere AC, Ferraro MJ.

Clin Infect Dis. 2011 Sep;53(6):541-7. doi: 10.1093/cid/cir464.


The VlsE (IR6) peptide ELISA in the serodiagnosis of lyme facial paralysis.

Peltomaa M, McHugh G, Steere AC.

Otol Neurotol. 2004 Sep;25(5):838-41.


C6 Peptide-Based Multiplex Phosphorescence Analysis (PHOSPHAN) for Serologic Confirmation of Lyme Borreliosis.

Pomelova VG, Korenberg EI, Kuznetsova TI, Bychenkova TA, Bekman NI, Osin NS.

PLoS One. 2015 Jul 6;10(7):e0130048. doi: 10.1371/journal.pone.0130048. eCollection 2015.


Evaluation of in vivo expressed Borrelia burgdorferi antigens for improved IgM serodiagnosis of early Lyme disease.

Brandt KS, Ullmann AJ, Molins CR, Horiuchi K, Biggerstaff BJ, Gilmore RD.

Diagn Microbiol Infect Dis. 2019 Mar;93(3):196-202. doi: 10.1016/j.diagmicrobio.2018.09.012. Epub 2018 Oct 3.


Antibodies to Borrelia burgdorferi OspA, OspC, OspF, and C6 antigens as markers for early and late infection in dogs.

Wagner B, Freer H, Rollins A, Garcia-Tapia D, Erb HN, Earnhart C, Marconi R, Meeus P.

Clin Vaccine Immunol. 2012 Apr;19(4):527-35. doi: 10.1128/CVI.05653-11. Epub 2012 Feb 15.


BBK07 immunodominant peptides as serodiagnostic markers of Lyme disease.

Coleman AS, Rossmann E, Yang X, Song H, Lamichhane CM, Iyer R, Schwartz I, Pal U.

Clin Vaccine Immunol. 2011 Mar;18(3):406-13. doi: 10.1128/CVI.00461-10. Epub 2010 Dec 22.

Supplemental Content

Support Center